Challenging go/no-go decision scenarios and design recommendations in phase II oncology trials
Saved in:
| Main Authors: | Dandan Kong, Huilei Miao, Xuejing Zhang, Huiyao Huang, Ning Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Journal of the National Cancer Center |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667005425000663 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A bootstrapping method to optimize go/no‐go decisions from single‐arm, signal‐finding studies in oncology
by: Raunak Dutta, et al.
Published: (2024-08-01) -
drugdevelopR: Planning of phase II/III drug development programs with optimal sample size allocation and Go/No-go decision rules in R
by: Johannes Cepicka, et al.
Published: (2025-05-01) -
Dive Right In With 'Penguins Ready to Go, Go, Go!'
by: Zach Greenberg
Published: (2024-12-01) -
Reflections and insights into the evolution of restrictive eligibility criteria for cancer clinical trials in China and beyond
by: Huiyao Huang, et al.
Published: (2025-06-01) -
Trends of drug licensing in China: From bring-in to go-global
by: Yale Jiang, et al.
Published: (2024-12-01)